AHRQ Singles Out “Priority Conditions” For Comparing Drug Effectiveness
This article was originally published in The Pink Sheet Daily
Executive Summary
The Agency for Healthcare Research & Quality will conduct comparative research on drugs used for 10 of the top conditions affecting Medicare beneficiaries, including ischemic heart disease, asthma and stroke. AHRQ will use the $15 mil. provided in the fiscal year 2005 omnibus appropriations bill.